We are live on ! Find out more
BPC

Banque Pictet & Cie Portfolio holdings

AUM $16B
1-Year Est. Return 29.1%
This Fund
S&P 500
This Quarter Est. Return
+5.07%
1 Year Est. Return
+29.1%
3 Year Est. Return
+74.82%
5 Year Est. Return
+105.76%
10 Year Est. Return
+488.78%
AUM
$4B
AUM Growth
+$341M
Cap. Flow
+$115M
Cap. Flow %
2.87%
Top 10 Hldgs %
32.71%
Holding
502
New
78
Increased
165
Reduced
119
Closed
42

Top Buys

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$33.7M
2
AXP icon
American Express
AXP
+$22.6M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$19.2M
4
TMO icon
Thermo Fisher Scientific
TMO
+$17.3M
5
ABT icon
Abbott
ABT
+$16.8M

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$115M
2
GM icon
General Motors
GM
+$25.2M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$24M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$19.4M
5
IJK icon
iShares S&P Mid-Cap 400 Growth ETF
IJK
+$10.4M

Sector Composition

Rank Sector Weight
1 Financials 12.63%
2 Consumer Discretionary 11.72%
3 Consumer Staples 10.11%
4 Technology 9.51%
5 Energy 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGLD icon
426
Royal Gold
RGLD
$19.5B
$205K 0.01%
+2,696
New +$178K
SCCO icon
427
Southern Copper
SCCO
$166B
$205K 0.01%
+7,281
New +$200K
EGRX
428
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$195K ﹤0.01%
13,587
+2,030
+18% +$23.1K
IAU icon
429
iShares Gold Trust
IAU
$64.4B
$193K ﹤0.01%
7,500
– –
BTU
430
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
$193K ﹤0.01%
787
– –
ICMB icon
431
Investcorp Credit Management BDC
ICMB
$12.1M
$188K ﹤0.01%
12,970
+1,938
+18% +$27.2K
VCYT icon
432
Veracyte
VCYT
$3.8B
$185K ﹤0.01%
+10,783
New +$155K
EGO icon
433
Eldorado Gold
EGO
$9.89B
$178K ﹤0.01%
4,650
+97
+2% +$2.97K
RBCN
434
DELISTED
Rubicon Technology, Inc.
RBCN
$175K ﹤0.01%
2,000
– –
TVRD
435
Tvardi Therapeutics
TVRD
$23.4M
$171K ﹤0.01%
+280
New +$151K
HSTO
436
DELISTED
Histogen Inc. Common Stock
HSTO
$170K ﹤0.01%
93
+14
+18% +$18.7K
NCFT
437
DELISTED
NORCRAFT COS INC COM STK (DE)
NCFT
$167K ﹤0.01%
+11,638
New +$189K
PAYC icon
438
Paycom
PAYC
$9.69B
$165K ﹤0.01%
+11,305
New +$165K
CARM
439
DELISTED
Carisma Therapeutics
CARM
$154K ﹤0.01%
+586
New +$145K
AKAO
440
DELISTED
Achaogen Inc
AKAO
$153K ﹤0.01%
+10,930
New +$153K
FRSH
441
DELISTED
Papa Murphy's Holdings, Inc
FRSH
$149K ﹤0.01%
+15,552
New +$154K
EGLT
442
DELISTED
Egalet Corporation
EGLT
$146K ﹤0.01%
+11,130
New +$139K
FRO icon
443
Frontline
FRO
$8.85B
$141K ﹤0.01%
9,640
– –
CNCE
444
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$137K ﹤0.01%
13,575
+2,029
+18% +$19.6K
FLXN
445
DELISTED
Flexion Therapeutics, Inc.
FLXN
$135K ﹤0.01%
+10,035
New +$137K
XPL icon
446
Solitario Resources
XPL
$72.9M
$132K ﹤0.01%
100,000
– –
TRVN
447
DELISTED
Trevena, Inc.
TRVN
$130K ﹤0.01%
37
+6
+19% +$18.7K
NGD
448
DELISTED
New Gold Inc
NGD
$127K ﹤0.01%
19,971
+415
+2% +$2.24K
KGC icon
449
Kinross Gold
KGC
$32.8B
$124K ﹤0.01%
29,894
+607
+2% +$2.47K
CBIO
450
Crescent Biopharma
CBIO
$626M
$109K ﹤0.01%
130
+20
+18% +$19.9K
16 17
18
19 20

Similar funds

MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
CCMG
Clark Capital Management Group Philadelphia, Pennsylvania $16.2B AUM 29.8% 1-Year Est. Return
CLGM
Capitolis Liquid Global Markets New York $15.7B AUM 30.78% 1-Year Est. Return
LCOV
London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return
LCIP
Life Cycle Investment Partners London $15.7B AUM
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
EF
Empowered Funds Havertown, Pennsylvania $15.7B AUM 34.02% 1-Year Est. Return
IG
ING Group Amsterdam, Netherlands $16.4B AUM 34.6% 1-Year Est. Return

Banque Pictet & Cie's Q2 2014 Portfolio in Review

As of Q2 2014, Banque Pictet & Cie held 502 positions worth $4B, up 9.3% from $3.66B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Banque Pictet & Cie's Q2 2014 filing shows 78 new, 165 increased, 119 reduced and 42 closed positions. Its largest new stake was Thermo Fisher Scientific: 147,040 shares worth $17.4M. The largest sale was Allergan Inc, an estimated $115M.

By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

  • Banque Pictet & Cie's largest Q2 2014 buy was Thermo Fisher Scientific: 147,040 shares worth $17.4M.
  • Banque Pictet & Cie added most to Starbucks in Q2 2014, an estimated $33.7M increase.
  • Banque Pictet & Cie's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $115M.
  • Banque Pictet & Cie fully exited iShares S&P Mid-Cap 400 Growth ETF in Q2 2014, selling an estimated $10.4M.
  • Banque Pictet & Cie's ten largest holdings make up 33% of its $4B portfolio in Q2 2014.
  • Banque Pictet & Cie opened 78 new positions and closed 42 in Q2 2014.
  • Banque Pictet & Cie's portfolio value rose 9.3% quarter-over-quarter to $4B.

Based on Banque Pictet & Cie's 13F filing for Q2 2014, filed 6 Aug 2014.